Persistent inhibition of platelets during continuous nitroglycerin therapy despite hemodynamic tolerance

Area of Science:

• Cardiovascular Pharmacology
• Hemodynamics
• Platelet Biology

Background:

• Nitroglycerin exhibits antiplatelet properties in both animal and human studies.
• Tolerance to nitroglycerin's hemodynamic effects is known to occur with continuous therapy.
• The persistence of nitroglycerin's antiplatelet effect during continuous therapy remains unclear.

Purpose of the Study:

• To investigate whether tolerance develops to the antiplatelet effects of continuous nitroglycerin therapy.
• To assess the impact of sustained nitroglycerin administration on platelet function and deposition.

Main Methods:

• Porcine aortic media was exposed to arterial blood from control pigs and pigs receiving continuous nitroglycerin patches (0.8 mg/h).
• Platelet deposition on aortic media was measured using autologous 51Cr-labeled platelets under high shear conditions.
• Platelet aggregation induced by thrombin and intraplatelet cyclic guanosine monophosphate (cGMP) levels were assessed.

Main Results:

• Continuous nitroglycerin treatment significantly reduced platelet deposition on aortic media at 3, 24, and 48 hours compared to baseline.
• Thrombin-induced platelet aggregation decreased significantly throughout the 48-hour treatment period.
• Nitroglycerin administration led to increased intraplatelet cGMP levels, indicating sustained pharmacological action.

Conclusions:

• Continuous nitroglycerin therapy maintains its antiplatelet efficacy despite the development of tolerance to its hemodynamic effects.
• The study demonstrates persistent inhibition of platelet function and deposition on injured arterial walls with sustained nitroglycerin use.
• These findings highlight the importance of nitroglycerin's antiplatelet action in managing cardiovascular conditions.